These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32430427)

  • 1. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
    McAlinden KD; Eapen MS; Lu W; Chia C; Haug G; Sohal SS
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 and COPD: A Personal Reflection.
    Russell R
    Int J Chron Obstruct Pulmon Dis; 2020; 15():883-884. PubMed ID: 32425514
    [No Abstract]   [Full Text] [Related]  

  • 3. The EVALI outbreak and vaping in the COVID-19 era.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2020 Sep; 8(9):831. PubMed ID: 32805203
    [No Abstract]   [Full Text] [Related]  

  • 4. Host genetic factors and susceptibility to SARS-CoV-2 infection.
    Schurr TG
    Am J Hum Biol; 2020 Sep; 32(5):e23497. PubMed ID: 32876373
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking, ACE-2 and COVID-19: ongoing controversies.
    Leung JM; Sin DD
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
    Narasaraju T
    Ann Intern Med; 2020 Aug; 173(4):323-324. PubMed ID: 32805179
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
    Zhang H; Wang CY; Zhou P; Yue H; Du R
    Ann Intern Med; 2020 Aug; 173(4):324. PubMed ID: 32805177
    [No Abstract]   [Full Text] [Related]  

  • 8. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease.
    McAlinden KD; Eapen MS; Lu W; Sharma P; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L585-L595. PubMed ID: 32726146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of serology testing to manage SARS-CoV-2 infections.
    Fernández-Barat L; López-Aladid R; Torres A
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32675201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Response to SARS-CoV-2/COVID-19.
    Burger CD; Mikhail AE; Orenstein R; Ebbert JO; Vergidis P; Badley AD
    Mayo Clin Proc; 2020 Sep; 95(9S):S52-S55. PubMed ID: 32807524
    [No Abstract]   [Full Text] [Related]  

  • 11. Addressing the intersection between COVID-19 and young people vaping: timely resources needed.
    Bandara NA; Herath J; Mehrnoush V
    CMAJ; 2020 Oct; 192(43):E1310. PubMed ID: 33106304
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic.
    Kaye L; Theye B; Smeenk I; Gondalia R; Barrett MA; Stempel DA
    J Allergy Clin Immunol Pract; 2020; 8(7):2384-2385. PubMed ID: 32371047
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Outbreak: An Overview on Dentistry.
    Spagnuolo G; De Vito D; Rengo S; Tatullo M
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32235685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    Chan KH; Slim J
    Emerg Infect Dis; 2020 Oct; 26(10):2535. PubMed ID: 32614765
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.
    Du RH; Liang LR; Yang CQ; Wang W; Cao TZ; Li M; Guo GY; Du J; Zheng CL; Zhu Q; Hu M; Li XY; Peng P; Shi HZ
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32907886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD.
    Press VG; Gershon AS; Sciurba FC; Blagev DP
    Chest; 2020 Sep; 158(3):866-868. PubMed ID: 32473947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cerebral venous thrombosis and SARS-CoV-2 infection].
    Dahl-Cruz F; Guevara-Dalrymple N; López-Hernández N
    Rev Neurol; 2020 May; 70(10):391-392. PubMed ID: 32390132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection.
    Frija-Masson J; Debray MP; Gilbert M; Lescure FX; Travert F; Borie R; Khalil A; Crestani B; d'Ortho MP; Bancal C
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32554533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-dependent surface stability of SARS-CoV-2.
    Kratzel A; Steiner S; Todt D; V'kovski P; Brueggemann Y; Steinmann J; Steinmann E; Thiel V; Pfaender S
    J Infect; 2020 Sep; 81(3):452-482. PubMed ID: 32504748
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 Infection Fatality Rates: The Author Replies.
    Basu A
    Health Aff (Millwood); 2020 Aug; 39(8):1462-1463. PubMed ID: 32744937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.